Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 20.79 M18.22 M15.94 M18.86 M 73.81 M Research & development ———— — Operating income 31.99 M46.27 M52.11 M248.68 M 379.05 M Non-Operating Income, Total -32.2 M-18.64 M-32.37 M164.38 M 81.17 M Interest expense, net of interest capitalized 376.47 M373.67 M370.01 M374.75 M 1.49 B Non-Operating Income, excl. Interest Expenses -408.67 M-392.31 M-402.38 M-210.37 M -1.41 B Unusual income/expense ———— — Pretax income 4.66 M19.56 M22.9 M215.94 M 263.07 M Equity in earnings ———— — Taxes -20 K6 000162 K186 K 334 K Non-controlling/minority interest -84 K-39 K349 K398 K 624 K After tax other income/expense ———— — Net income before discontinued operations 4.77 M19.6 M22.39 M215.36 M 262.11 M Discontinued operations ———— — Net income 4.77 M19.6 M22.39 M215.36 M 262.11 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 4.77 M19.6 M22.39 M215.36 M 262.11 M Basic earnings per share (Basic EPS) ———— — Diluted earnings per share (Diluted EPS) ———— — Average basic shares outstanding ———— — Diluted shares outstanding ———— — EBITDA -348.16 M-330.74 M-321.33 M-130.36 M -1.13 B EBIT -351.56 M-334.08 M-324.7 M-134.23 M -1.14 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 3.39 M3.34 M3.36 M3.87 M 13.97 M